Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 24001749)

1.

Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics.

Haissaguerre M, Courel M, Caron P, Denost S, Dubessy C, Gosse P, Appavoupoulle V, Belleannée G, Jullié ML, Montero-Hadjadje M, Yon L, Corcuff JB, Fagour C, Mazerolles C, Wagner T, Nunes ML, Anouar Y, Tabarin A.

J Clin Endocrinol Metab. 2013 Nov;98(11):4346-54. doi: 10.1210/jc.2013-1844. Epub 2013 Sep 3.

PMID:
24001749
3.

6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.

Fottner C, Helisch A, Anlauf M, Rossmann H, Musholt TJ, Kreft A, Schadmand-Fischer S, Bartenstein P, Lackner KJ, Klöppel G, Schreckenberger M, Weber MM.

J Clin Endocrinol Metab. 2010 Jun;95(6):2800-10. doi: 10.1210/jc.2009-2352. Epub 2010 Apr 6.

PMID:
20371665
4.
5.

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas.

van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SW, van de Meiracker AH, Boomsma F, Stijnen T, Krenning EP, Bosman FT, Kwekkeboom DJ.

J Clin Endocrinol Metab. 2001 Feb;86(2):685-93.

PMID:
11158032
6.

Clinical diagnosis and treatment of nonfunctioning pheochromocytomas in 14 patients.

Pan DL, Li HZ, Zeng ZP, Li F, Cui QC.

Chin Med Sci J. 2005 Jun;20(2):126-8.

PMID:
16075754
7.

Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas.

Lafont M, Fagour C, Haissaguerre M, Darancette G, Wagner T, Corcuff JB, Tabarin A.

J Clin Endocrinol Metab. 2015 Feb;100(2):417-21. doi: 10.1210/jc.2014-2998. Epub 2014 Nov 18.

PMID:
25405501
8.

Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.

Jansson S, Tisell LE, Fjälling M, Lindberg S, Jacobsson L, Zachrisson BF.

Surgery. 1988 Jan;103(1):11-8.

PMID:
2892276
9.

6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.

Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, Jager PL, Elsinga PH, Dierckx RA, van der Wal JE, Sluiter WJ, de Vries EG, Links TP.

J Clin Endocrinol Metab. 2009 Oct;94(10):3922-30. doi: 10.1210/jc.2009-1054. Epub 2009 Jul 21.

PMID:
19622618
10.

Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.

Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M, Ghossein RA.

Surgery. 2008 Jun;143(6):759-68. doi: 10.1016/j.surg.2008.02.007. Epub 2008 Apr 14.

PMID:
18549892
11.

Iodine-131-MIBG scintigraphy in adults: interpretation revisited?

Roelants V, Goulios C, Beckers C, Jamar F.

J Nucl Med. 1998 Jun;39(6):1007-12.

12.

Diagnostic value of serum chromogranin-A combined with MIBG scintigraphy inpatients with adrenal incidentalomas.

Giovanella L, Ceriani L, Balerna M, Keller F, Taborelli M, Marone C, Ferone D.

Q J Nucl Med Mol Imaging. 2008 Mar;52(1):84-88.

13.

Granins and their derived peptides in normal and tumoral chromaffin tissue: Implications for the diagnosis and prognosis of pheochromocytoma.

Guérin M, Guillemot J, Thouënnon E, Pierre A, El-Yamani FZ, Montero-Hadjadje M, Dubessy C, Magoul R, Lihrmann I, Anouar Y, Yon L.

Regul Pept. 2010 Nov 30;165(1):21-9. doi: 10.1016/j.regpep.2010.06.003. Epub 2010 Jun 18. Review.

PMID:
20600356
14.

[Nuclear medicine diagnosis of pheochromocytoma with metaiodobenzylguanidine].

Pucar D, Marković S.

Srp Arh Celok Lek. 2002 Jul;130 Suppl 2:20-4. Serbian.

PMID:
12584993
15.

MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results.

Maurea S, Fiumara G, Pellegrino T, Zampella E, Assante R, Mainenti P, Cuocolo A.

Cancer Imaging. 2013 Apr 15;13:155-61. doi: 10.1102/1470-7330.2013.0017.

16.

Differential expression and processing of secretogranin II in relation to the status of pheochromocytoma: implications for the production of the tumoral marker EM66.

Guillemot J, Thouënnon E, Guérin M, Vallet-Erdtmann V, Ravni A, Montéro-Hadjadje M, Lefebvre H, Klein M, Muresan M, Seidah NG, Anouar Y, Yon L.

J Mol Endocrinol. 2012 Feb 6;48(2):115-27. doi: 10.1530/JME-11-0077. Print 2012 Apr.

17.

The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma.

Greenblatt DY, Shenker Y, Chen H.

Ann Surg Oncol. 2008 Mar;15(3):900-5. doi: 10.1245/s10434-007-9776-y. Epub 2008 Jan 8.

PMID:
18193324
18.

Clinically silent chromaffin-cell tumors: Tumor characteristics and long-term prognosis in patients with incidentally discovered pheochromocytomas.

Grozinsky-Glasberg S, Szalat A, Benbassat CA, Gorshtein A, Weinstein R, Hirsch D, Shraga-Slutzky I, Tsvetov G, Gross DJ, Shimon I.

J Endocrinol Invest. 2010 Nov;33(10):739-44. doi: 10.3275/7043. Epub 2010 May 17.

PMID:
20479567
19.

Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas.

Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH.

AJR Am J Roentgenol. 2005 Sep;185(3):684-8.

PMID:
16120918
20.

Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas.

Havekes B, van der Klaauw AA, Weiss MM, Jansen JC, van der Mey AG, Vriends AH, Bonsing BA, Romijn JA, Corssmit EP.

Endocr Relat Cancer. 2009 Jun;16(2):527-36. doi: 10.1677/ERC-09-0024. Epub 2009 Mar 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk